MedTrace Logo

Glycemic and Appetite Effects of a Pre-meal Whey-Protein Microgel

NCT06593769 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2025-02-07

No results posted yet for this study

Summary

In this study, the investigators want to assess the effects of a short-term twice daily pre-meal consumption of a liquid whey-protein microgel formulation, when compared to placebo (i.e., water), on:

* post-prandial glucose
* appetite This is an open-label study in 18 overweight or obese participants. This study will be performed in one center, the Clinical Innovation Laboratory (CIL), Nestlé Research, Lausanne. Participants will be screened and randomly assigned to 1 of 2 sequences of consumption. Enrolled participants will then consume the test product, or placebo, pre-breakfast and pre-lunch for four days and then crossover to the other product, over a period of 12 days.

Conditions

  • Glucose Metabolism
  • Appetite Regulation

Interventions

DIETARY_SUPPLEMENT

whey-protein microgel

The product used in this study is a liquid 125 mL whey protein microgel (WPM) formulation that will be delivered in a ready-to-drink formulation. The WPM is dairy based and, aside from milk and lactose, no other allergens are present Whey proteins and caseinates are two major fractions of cow milk proteins.

OTHER

Placebo

Water (isovoloumous amount)

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Nora Schneider · Nestlé Research

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-09
Primary Completion
2024-12-20
Completion
2024-12-23

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06593769 on ClinicalTrials.gov